Press Releases
Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements of the In Vitro Diagnostics Directive (IVDD 98/79/EC) and has CE marked (Conformité Européenne) its...
Press Releases
Notable and MDS Foundation Partner on MDS Trials and New Drug Therapies
California-based Notable announced that it has entered a partnership with the MDS Foundation, which is dedicated to providing insight to families on future clinical trials for myelodysplastic syndrome (MDS).
Notable will offer a grant to support the MDS Foundation’s education...
Press Releases
Geneius Develops Off-the-Shelf T Cell Therapy Targeting SARS-CoV-2
Geneius Biotechnology is developing T cells as a quasi-personalized, off-the-shelf, therapy and preventive measure against COVID-19. The assumption is that by increasing the number of antigen-specific T cells in the body, the patient’s immune system can overwhelm the SARS-CoV-2...
Press Releases
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and Lonza Ltd. announced a 10-year strategic collaboration agreement to enable larger scale manufacture of...
Press Releases
Fujifilm Diosynth Biotechnologies Teams with COVID-19 Therapeutics Accelerator
FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 Therapeutics Accelerator. The Therapeutics Accelerator is an initiative launched by the Bill...
Packaging & Labelling
WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility
WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that its robotic aseptic filling isolator facility (DP4) has successfully completed the filling of two batches of pre-filled syringes (PFS).
Using Vanrx SA25 to fill the two batches,...
Press Releases
Hardy Diagnostics announces FDA EUA for antibody test and increases manufacturing capacity for COVID-19 products
Hardy Diagnostics, a medical device manufacturer based in Santa Maria, California, announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test (Cat. No. RTA0203).
This immunoassay is intended for qualitative detection and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read